Table 4.

Patient characteristics of the 40 PICU cases with delirium 2002–2005

No.	Sex	Age	Primary diagnosis on admission PICU	Mechanical ventilation	Delirium type	Treatment
1	M	3 months	Multiple congenital malformations	+	Emerging	Haloperidol
2	F	4 months	Meningococcal septic shock	+	Emerging	Risperidone
3	M	4.5 months	Severe CLD	+	Emerging	Risperidone
4	F	10 months	Near drowning	+	Emerging	Haloperidol
5	F	1 year	Pneumonia	+	Emerging	Haloperidol
6	M	1 year	Sepsis due to perforated appendicitis	+	Emerging	Haloperidol
7	M	1 year	Subarachnoid bleeding	+	Emerging	Haloperidol
8	M	1 year	Pericardial effusion with pretamponade	+	Hyperactive	Haloperidol
9	M	1 year	Multiple dysmorphia, upper airway obstruction	–	Emerging	Haloperidol
10	F	2 years	Meningococcal septic shock	+	Hyperactive	Haloperidol
11	M	2 years	ADEM	+	Hyperactive	Risperidone
12	M	2 years	Cervical mass, upper airway obstruction	+	Emerging	Haloperidol
13	M	2 years	Aspiration and pneumothorax	+	Hypoactive	–
14	F	2 years	Meningococcal meningitis with sepsis and DIC	+	Hyperactive	Haloperidol
15	F	3 years	Cystic fibrosis and pneumonia	+	Hypoactive	Haloperidol
16	M	4 years	Intracerebral hemorrhage, Marfan syndrome	+	Hypoactive	Haloperidol
17	M	5 years	Medulloblastoma post surgery	+	Emerging	Risperidone
18	M	5 years	Upper respiratory tract infection	+	Hyperactive	Haloperidol
19	M	6 years	Multiple trauma	+	Emerging	Risperidone
20	F	8 years	Meningo-encephalitis	+	Hyperactive	Risperidone
21	F	8 years	Viral encephalitis	+	Hyperactive	–
22	F	9 years	Status asthmaticus	+	Hyperactive	Risperidone
23	F	9 years	TBI, gunshot wound	+	Hypoactive	Risperidone
24	M	9 years	Status asthmaticus	+	Hyperactive	Haloperidol
25	M	9 years	Neural tube defect and drain dysfunction	–	Emerging	first Haloperidol, then Risperidone
26	M	11 years	Hypovolemic shock, typhus abdominalis	–	Hyperactive	Haloperidol
27	F	12 years	TBI	+	Hypoactive	Haloperidol
28	M	12 years	TBI and fracture of lower leg	+	Emerging	Haloperidol
29	M	13 years	Sepsis, paronychia	–	Hyperactive	Haloperidol
30	M	13 years	Status epilepticus	+	Emerging	Haloperidol
31	F	14 years	TBI	+	Hyperactive	Haloperidol
32	F	15 years	Post TBI	+	Hypoactive	Haloperidol
33	M	15 years	Postoperative state	+	Hypoactive	Risperidone
34	M	15 years	Acute lymphoblastic leukemia	–	Hypoactive	Haloperidol
35	M	15 years	TBI	+	Emerging	Haloperidol
36	F	15 years	Status asthmaticus	+	Hyperactive	Haloperidol
37	M	16 years	Multiple trauma	–	Hypoactive	Haloperidol
38	F	16 years	Bacterial meningitis	+	Hyperactive	Risperidone
39	M	16 years	Respiratory failure, Duchenne disease	+	Emerging	Haloperidol
40	M	17 years	Septic shock	+	Emerging	Haloperidol

CLD, chronic lung disease; ADEM, acute disseminated encephalomyelitis; DIC, diffuse intravascular coagulation; TBI, traumatic brain injury